$142.70
-0.59-0.41%
Last update: Oct 23, 4:47 PM
Neurocrine Biosciences Inc (NBIX) Stock Price, Quote, News & History
NBIXNASDAQ
Neurocrine (NBIX) to acquire Soleno Therapeutics (SLNO) for $2.9B to expand its rare disease portfolio. Get the deal details here.
You can purchase shares of Neurocrine Biosciences (NASDAQ:NBIX) through any online brokerage.
Other companies in Neurocrine Biosciences’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).
Neurocrine Biosciences has a consensus price target of $201.32.
The stock price for Neurocrine Biosciences (NASDAQ: NBIX) is $141.5 last updated October 23, 2026 at 4:47 PM EDT.
There are no upcoming dividends for Neurocrine Biosciences.
Neurocrine Biosciences does not have any upcoming earnings scheduled.
There is no upcoming split for Neurocrine Biosciences.
Neurocrine Biosciences is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.
Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions...
